Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4): evaluation and management of adverse drug reactions

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Hassel, Jessica C. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 18 May 2017
In: Cancer treatment reviews
Year: 2017, Jahrgang: 57, Pages: 36-49
ISSN:1532-1967
DOI:10.1016/j.ctrv.2017.05.003
Online-Zugang:Verlag, Pay-per-use, Volltext: https://doi.org/10.1016/j.ctrv.2017.05.003
Volltext
Verfasserangaben:Jessica C. Hassel, Lucie Heinzerling, Jens Aberle, Oliver Bähr, Thomas K. Eigentler, Marc-Oliver Grimm, Victor Grünwald, Jan Leipe, Niels Reinmuth, Julia K. Tietze, Jörg Trojan, Lisa Zimmer, Ralf Gutzmer

MARC

LEADER 00000caa a2200000 c 4500
001 1580831842
003 DE-627
005 20220815004409.0
007 cr uuu---uuuuu
008 180910s2017 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.ctrv.2017.05.003  |2 doi 
035 |a (DE-627)1580831842 
035 |a (DE-576)510831842 
035 |a (DE-599)BSZ510831842 
035 |a (OCoLC)1341018411 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Hassel, Jessica C.  |d 1975-  |e VerfasserIn  |0 (DE-588)129790702  |0 (DE-627)480399069  |0 (DE-576)29783715X  |4 aut 
245 1 0 |a Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4)  |b evaluation and management of adverse drug reactions  |c Jessica C. Hassel, Lucie Heinzerling, Jens Aberle, Oliver Bähr, Thomas K. Eigentler, Marc-Oliver Grimm, Victor Grünwald, Jan Leipe, Niels Reinmuth, Julia K. Tietze, Jörg Trojan, Lisa Zimmer, Ralf Gutzmer 
264 1 |c 18 May 2017 
300 |a 14 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 10.09.2018 
773 0 8 |i Enthalten in  |t Cancer treatment reviews  |d Amsterdam [u.a.] : Elsevier, 1974  |g 57(2017), Seite 36-49  |h Online-Ressource  |w (DE-627)320417158  |w (DE-600)2002084-3  |w (DE-576)104194154  |x 1532-1967  |7 nnas  |a Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4) evaluation and management of adverse drug reactions 
773 1 8 |g volume:57  |g year:2017  |g pages:36-49  |g extent:14  |a Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4) evaluation and management of adverse drug reactions 
856 4 0 |u https://doi.org/10.1016/j.ctrv.2017.05.003  |x Verlag  |x Resolving-System  |z Pay-per-use  |3 Volltext 
951 |a AR 
992 |a 20180910 
993 |a Article 
994 |a 2017 
998 |g 129790702  |a Hassel, Jessica C.  |m 129790702:Hassel, Jessica C.  |d 910000  |d 911300  |e 910000PH129790702  |e 911300PH129790702  |k 0/910000/  |k 1/910000/911300/  |p 1  |x j 
999 |a KXP-PPN1580831842  |e 3025223677 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Jessica C. Hassel, Lucie Heinzerling, Jens Aberle, Oliver Bähr, Thomas K. Eigentler, Marc-Oliver Grimm, Victor Grünwald, Jan Leipe, Niels Reinmuth, Julia K. Tietze, Jörg Trojan, Lisa Zimmer, Ralf Gutzmer"]},"id":{"doi":["10.1016/j.ctrv.2017.05.003"],"eki":["1580831842"]},"recId":"1580831842","physDesc":[{"extent":"14 S."}],"person":[{"display":"Hassel, Jessica C.","family":"Hassel","given":"Jessica C.","role":"aut"}],"relHost":[{"disp":"Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4) evaluation and management of adverse drug reactionsCancer treatment reviews","recId":"320417158","physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1532-1967"],"eki":["320417158"],"zdb":["2002084-3"]},"title":[{"title":"Cancer treatment reviews","title_sort":"Cancer treatment reviews"}],"part":{"extent":"14","text":"57(2017), Seite 36-49","volume":"57","year":"2017","pages":"36-49"},"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 22.01.2020"],"origin":[{"publisher":"Elsevier ; Harcourt","publisherPlace":"Amsterdam [u.a.] ; Burlington, Mass.","dateIssuedKey":"1974","dateIssuedDisp":"1974-"}],"pubHistory":["1.1974 -"]}],"origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"18 May 2017"}],"title":[{"title":"Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4)","title_sort":"Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4)","subtitle":"evaluation and management of adverse drug reactions"}],"note":["Gesehen am 10.09.2018"],"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"}} 
SRT |a HASSELJESSCOMBINEDIM1820